Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2000, p. 81-90, Vol. 20, No. 1
Huntsman Cancer Institute, University of
Utah, Salt Lake City, Utah 84112-5550,1 and
Department of Biochemistry, Dartmouth Medical School, Hanover,
New Hampshire 037552
Received 15 June 1999/Returned for modification 22 July
1999/Accepted 4 October 1999
Auto-inhibition is a common transcriptional control mechanism that
is well characterized in the regulatory transcription factor Ets-1.
Autoinhibition of Ets-1 DNA binding works through an inhibitory module
that exists in two conformations. DNA binding requires a change in the
inhibitory module from the packed to disrupted conformation. This
structural switch provides a mechanism to tightly regulate Ets-1 DNA
binding. We report that the Ets-1 partner protein core-binding factor
0270-7306/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Auto-Inhibition of Ets-1 Is Counteracted by DNA
Binding Cooperativity with Core-Binding Factor
2
2 (CBF
2; also known as AML1 or PEBP2) stimulates Ets-1 DNA
binding and counteracts auto-inhibition. Support for this conclusion
came from three observations. First, the level of cooperative DNA
binding (10-fold) was similar to the level of repression by
auto-inhibition (10- to 20-fold). Next, a region necessary for
cooperative DNA binding mapped to the inhibitory module. Third, an
Ets-1 mutant with a constitutively disrupted inhibitory module did not
bind DNA cooperatively with CBF
2. Furthermore, two additional lines
of evidence indicated that CBF
2 affects the structural switch by
direct interactions with Ets-1. First, the retention of cooperative DNA
binding on nicked duplexes eliminated a potential role of through-DNA
effects. Second, cooperative DNA binding was observed on composite
sites with altered spacing or reversed orientation. We suggest that
only protein interactions can accommodate this observed flexibility.
These findings provide a mechanism by which CBF relieves the
auto-inhibition of Ets-1 and illustrates one strategy for the
synergistic activity of regulatory transcription factors.
*
Corresponding author. Mailing address: Huntsman Cancer
Institute, University of Utah, Salt Lake City, UT 84112-5550. Phone: (801) 581-7308. Fax: (801) 585-1980. E-mail:
Barbara.Graves{at}hci.utah.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|